Academic
Radiation Oncology
Dr. Susan J. Knox, MD
|
|
Give Review
Susan J. Knox, MD is an expert in the field of Radiation Oncology. She researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. She has 1 awards "CMS Meaningful Use Stage 1 Certification". Susan Knox is a published doctor. She published 101 publications, including: 'Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.'
Publications
- Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases.
- CCR 20th anniversary commentary: Radioactive Drones for B-cell lymphoma.
- Novel human radiation exposure biomarker panel applicable for population triage.
- Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy.
- The Implications of Hyponitroxia in Cancer.
- Radioprotection and Cell Cycle Arrest of Intestinal Epithelial Cells by Darinaparsin, a Tumor Radiosensitizer.
- Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line.
- Mitigation of radiation-induced dermatitis by activation of aldehyde dehydrogenase 2 using topical alda-1 in mice.
- Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.
- Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials.
- Six degrees of separation: the oxygen effect in the development of radiosensitizers.
- In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.
- Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats.
- Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
- Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
- 131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.
- Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.
- Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
- Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo.
- MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy?
- Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.
- Targeting integrins and PI3K/Akt-mediated signal transduction pathways enhances radiation-induced anti-angiogenesis.
- Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.
- Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
- Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
- Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.
- Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation.
- Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma.
- Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab.
- Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lym...
- Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tos...
- Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
- Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia.
- The radioisotope contributes significantly to the activity of radioimmunotherapy.
- Enhancement of the efficacy of an antagonist of an extracellular receptor by attachment to the surface of a biocompatible carrier.
- Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
- Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
- Enhanced effectiveness of radiochemotherapy with tirapazamine by local application of electric pulses to tumors.
- Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
- A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
- Radiation-induced cyclooxygenase 2 up-regulation is dependent on redox status in prostate cancer cells.
- Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin).
- Distribution of monoclonal antiferritin antibody in Kaposi's sarcoma, Hodgkin's disease, and hepatocellular carcinoma.
- The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
- Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.
- Increasing realism among gay men in Sydney about HIV treatments: changes in attitudes over time.
- Growth of human T lymphocyte colonies from whole blood: culture requirements and applications.
- Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins.
- Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates.
- A prospective study of radiation therapy-associated thrombocytopenia.
- The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty.
- Results of the 1989 Association of Residents in Radiation Oncology survey.
- Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective c...
- The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy.
- The changing face of radiation oncology.
- Two independent pathways of helper activity provided by a single T cell clone.
- Radiation-induced inhibition of human lymphocyte blastogenesis: the effect of superoxide dismutase and catalase.
- Lack of relations of hostility, negative affect, and high-risk behavior with low plasma lipid levels in the Coronary Artery Risk Development in Young Adults Study.
- Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: in vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumera...
- Assessment of the in vitro radiosensitivity of human peripheral blood lymphocytes.
- Increased radiosensitivity of a subpopulation ot T-lymphocyte progenitors from patients with Fanconi's anemia.
- Effects of similarities in lifestyle habits on familial aggregation of high density lipoprotein and low density lipoprotein cholesterol: the NHLBI Family Heart Study.
- Association of BCL-2 with membrane hyperpolarization and radioresistance.
- Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).
- p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts.
- Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
- Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor.
- Mycosis fungoides arthropathy.
- Overview of studies on experimental radioimmunotherapy.
- Influence of Bcl-2 overexpression on Na+/K(+)-ATPase pump activity: correlation with radiation-induced programmed cell death.
- Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW.
- Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model.
- Clinical radioimmunotherapy.
- Risks to normal tissues from radionuclide therapy.
- The effect of stem cell factor on irradiated human bone marrow.
- Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice.
- Modulation of c-Myc activity and apoptosis in vivo.
- Dosimetry model for radioactivity localized to intestinal mucosa.
- Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation.
- The effect of unlabelled monoclonal antibody (mAb) on the biodistribution of 131I-anti-idiotype mAb in murine B cell lymphoma.
- Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization.
- The biodistribution of 111In-anti-bFGF in a variety of tumors. Correlation with cell-binding assays.
- Effects of stem cell factor on the growth and radiation survival of tumor cells.
- Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.
- Radiation sensitization with redox modulators: a promising approach.
- Hyperthermia and radiation therapy in the treatment of recurrent Merkel cell tumors.
- Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides.
- Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation.
- Bcl-2 overexpression results in enhanced capacitative calcium entry and resistance to SKF-96365-induced apoptosis.
- G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation.
- Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
- Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
- Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor.
- Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
- Radioimmunotherapy of B-cell NHL.
- Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
- Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
- Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
- Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.
- Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.
Schools
Stanford University School Of Medicine
Stanford University Hospital
University Ca Davis Med Center
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
University of California Davis -
Stanford University School of Medicine
Hospital
-
VA Palo Alto Health Care System -
Stanford Health Care -
Lucile Packard Children's Hospital Stanford
Drug Facts
| NPI NUMBER | 1912034240 | |
| NPPES Provider LastName | KNOX | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 943042205 | |
| NPPES Provider State | CA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 110.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912034240 |
| Last Name Of The Provider | KNOX |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
|
Dr. Michael D. Bastasch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Larson, MD
This Doctor is OpenDoctor Recommended.
|